Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study
Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study
Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study
Submitted by
admin
on December 29, 2016 - 10:12am
Source:
Endpoints
News Tags:
FDA
Cempra
antibiotics
Solithromycin
Headline:
Faced with a dilemma, the FDA rejects Cempra’s antibiotic, demands big safety study
Do Not Allow Advertisers to Use My Personal information
